19335274

Source:http://linkedlifedata.com/resource/pubmed/id/19335274

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016884, umls-concept:C0023467, umls-concept:C0087111, umls-concept:C0449438, umls-concept:C0449738, umls-concept:C0521116, umls-concept:C0599894, umls-concept:C1521840
pubmed:issue	4
pubmed:dateCreated	2009-4-1
pubmed:abstractText	The limit of acceptable toxicity for standard chemotherapeutic drugs used in acute myeloid leukaemia (AML) therapy has been reached. New therapeutic strategies are therefore needed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9434197
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1744-7658
pubmed:author	pubmed-author:BruserudØysteinØ, pubmed-author:GjertsenBjørn ToreBT, pubmed-author:ReikvamHåkonH, pubmed-author:StapnesCamillaC
pubmed:issnType	Electronic
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	433-55
pubmed:meshHeading	pubmed-meshheading:19335274-Antineoplastic Agents, pubmed-meshheading:19335274-Drug Design, pubmed-meshheading:19335274-Enzyme Inhibitors, pubmed-meshheading:19335274-Epigenesis, Genetic, pubmed-meshheading:19335274-Humans, pubmed-meshheading:19335274-Immunotherapy, pubmed-meshheading:19335274-Leukemia, Myeloid, Acute, pubmed-meshheading:19335274-Substrate Specificity
pubmed:year	2009
pubmed:articleTitle	Targeted therapy in acute myeloid leukaemia: current status and future directions.
pubmed:affiliation	Institute of Medicine, University of Bergen and Section for Haematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. Camilla.ingvaldsen.stapnes@helse-bergen.no
pubmed:publicationType	Journal Article, Review